Supplementary Figure 2 from Resistance to TRAIL Is Mediated by DARPP-32 in Gastric Cancer

PDF file, 1828KB, DARPP-32 blocks TRAIL-induced down-regulation of FLIP(S) expression in MKN-28 cells.</p

Supplementary Figure Legend from Resistance to TRAIL Is Mediated by DARPP-32 in Gastric Cancer

PDF file, 62KB.</p

Supplementary Figure 1 from Resistance to TRAIL Is Mediated by DARPP-32 in Gastric Cancer

PDF file, 144KB, DARPP-32 has no significant effect on NF-kB activation in MKN-28 cells.</p

Supplementary Figure S2 from Activation of EIF4E by Aurora Kinase A Depicts a Novel Druggable Axis in Everolimus-Resistant Cancer Cells

Supp Fig 2</p

Supp Figure S10 from A Combination of SAHA and Quinacrine Is Effective in Inducing Cancer Cell Death in Upper Gastrointestinal Cancers

Supp Figure S10</p

Supp Figure S2 from A Combination of SAHA and Quinacrine Is Effective in Inducing Cancer Cell Death in Upper Gastrointestinal Cancers

Supp Figure S2</p

Supplementary Figure S3 from Activation of EIF4E by Aurora Kinase A Depicts a Novel Druggable Axis in Everolimus-Resistant Cancer Cells

Supp Fig 3</p

Supp Figure S6 from A Combination of SAHA and Quinacrine Is Effective in Inducing Cancer Cell Death in Upper Gastrointestinal Cancers

Supp Figure S6</p

Supplementary Table S1 from Activation of EIF4E by Aurora Kinase A Depicts a Novel Druggable Axis in Everolimus-Resistant Cancer Cells

Supp Table 1</p

DNA copy number, methylation level and gene expression of GPX3 in gastric cancer cell lines.

<p>Copy number of the GPX3 gene was determined using qPCR and normalized to 10 normal blood DNA samples as described in the Methods section. The real copy number of each sample equals to the above copy number ratio times 2. DNA methylation levels were determined using Pyrosequencing and are shown as an average level of the 8 CpG sites in the GPX3 promoter region. GPX3 mRNA expression fold was determined using real-time RT-PCR and normalized to the average value of normal gastric samples as described in the Methods section.</p